1. Home
  2. VTMX vs AMRX Comparison

VTMX vs AMRX Comparison

Compare VTMX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • AMRX
  • Stock Information
  • Founded
  • VTMX 1998
  • AMRX 2002
  • Country
  • VTMX Mexico
  • AMRX United States
  • Employees
  • VTMX N/A
  • AMRX N/A
  • Industry
  • VTMX
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTMX
  • AMRX Health Care
  • Exchange
  • VTMX Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • VTMX 2.3B
  • AMRX 2.3B
  • IPO Year
  • VTMX 2023
  • AMRX N/A
  • Fundamental
  • Price
  • VTMX $28.84
  • AMRX $7.32
  • Analyst Decision
  • VTMX Sell
  • AMRX Strong Buy
  • Analyst Count
  • VTMX 2
  • AMRX 4
  • Target Price
  • VTMX $27.50
  • AMRX $11.50
  • AVG Volume (30 Days)
  • VTMX 263.0K
  • AMRX 1.9M
  • Earning Date
  • VTMX 07-24-2025
  • AMRX 05-02-2025
  • Dividend Yield
  • VTMX 2.46%
  • AMRX N/A
  • EPS Growth
  • VTMX N/A
  • AMRX N/A
  • EPS
  • VTMX 0.13
  • AMRX N/A
  • Revenue
  • VTMX $258,927,122.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • VTMX $17.35
  • AMRX $10.20
  • Revenue Next Year
  • VTMX $11.82
  • AMRX $7.15
  • P/E Ratio
  • VTMX $20.83
  • AMRX N/A
  • Revenue Growth
  • VTMX 15.06
  • AMRX 13.42
  • 52 Week Low
  • VTMX $21.30
  • AMRX $6.29
  • 52 Week High
  • VTMX $34.88
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 62.73
  • AMRX 46.61
  • Support Level
  • VTMX $28.96
  • AMRX $7.02
  • Resistance Level
  • VTMX $29.60
  • AMRX $7.39
  • Average True Range (ATR)
  • VTMX 0.73
  • AMRX 0.18
  • MACD
  • VTMX -0.12
  • AMRX -0.00
  • Stochastic Oscillator
  • VTMX 56.05
  • AMRX 45.80

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: